Susquehanna upgrades Idenix Pharmaceuticals (Nasdaq: IDIX) to Positive. Price target $8.

Susquehanna analyst says, "We are upgrading ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE